Literature DB >> 12144598

Morbidity associated with non-fatal heroin overdose.

Matthew Warner-Smith1, Shane Darke, Carolyn Day.   

Abstract

AIMS: To estimate the range and severity of heroin overdose related morbidity.
DESIGN: Cross-sectional survey.
SETTING: Sydney, Australia. PARTICIPANTS: 198 heroin users.
FINDINGS: Sixty-nine per cent had experienced a heroin overdose, 28% in the preceding 12 months. Of those who had overdosed, 79% had experienced at least one overdose-related morbidity symptom. An ambulance had attended overdoses for 59% of subjects, 33% had required hospital treatment for overdose, and 14% had experienced overdose-related complications of sufficient severity to be admitted to a hospital ward. Indirect overdose-related morbidity included: physical injury sustained when falling at overdose (40%), burns (24%) and assault while unconscious (14%). Direct overdose-related morbidity included: peripheral neuropathy (49%), vomiting (33%), temporary paralysis of limbs (26%), chest infections (13%) and seizure (2%).
CONCLUSIONS: There appears to be extensive morbidity associated with non-fatal overdose. This is clearly an area that requires more research to document the prevalence and nature of these harms, and factors associated with them.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144598     DOI: 10.1046/j.1360-0443.2002.00132.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  65 in total

1.  Characteristics of drug users who witness many overdoses: implications for overdose prevention.

Authors:  Amy S B Bohnert; Melissa Tracy; Sandro Galea
Journal:  Drug Alcohol Depend       Date:  2011-08-12       Impact factor: 4.492

2.  Policing and risk of overdose mortality in urban neighborhoods.

Authors:  Amy S B Bohnert; Arijit Nandi; Melissa Tracy; Magdalena Cerdá; Kenneth J Tardiff; David Vlahov; Sandro Galea
Journal:  Drug Alcohol Depend       Date:  2010-08-19       Impact factor: 4.492

Review 3.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

4.  Preventing opiate overdose deaths: examining objections to take-home naloxone.

Authors:  Alexander R Bazazi; Nickolas D Zaller; Jeannia J Fu; Josiah D Rich
Journal:  J Health Care Poor Underserved       Date:  2010-11

5.  Perceived Severity of and Susceptibility to Overdose Among Injection Drug Users: Relationships With Overdose History.

Authors:  Erin E Bonar; Amy S B Bohnert
Journal:  Subst Use Misuse       Date:  2016-05-31       Impact factor: 2.164

6.  Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users.

Authors:  Stuart A Kinner; M-J Milloy; Evan Wood; Jiezhi Qi; Ruth Zhang; Thomas Kerr
Journal:  Addict Behav       Date:  2012-02-07       Impact factor: 3.913

7.  Are non-fatal opioid overdoses misclassified suicide attempts? Comparing the associated correlates.

Authors:  Elizabeth Maloney; Louisa Degenhardt; Shane Darke; Elliot C Nelson
Journal:  Addict Behav       Date:  2009-05-03       Impact factor: 3.913

8.  Gender differences in health related quality of life of young heroin users.

Authors:  Antònia Domingo-Salvany; M Teresa Brugal; Gregorio Barrio; Francisco González-Saiz; M José Bravo; Luís de la Fuente
Journal:  Health Qual Life Outcomes       Date:  2010-12-01       Impact factor: 3.186

9.  Can we prevent drug related deaths by training opioid users to recognise and manage overdoses?

Authors:  Romina Lopez Gaston; David Best; Victoria Manning; Ed Day
Journal:  Harm Reduct J       Date:  2009-09-25

10.  Characteristics of inmates witnessing overdose events in prison: implications for prevention in the correctional setting.

Authors:  Carmen E Albizu-García; Adriana Hernández-Viver; Jacqueline Feal; José F Rodríguez-Orengo
Journal:  Harm Reduct J       Date:  2009-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.